|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02367 GIANT BIOGENE
Nominal 
50.100 -1.100 (-2.148%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 2,540,432 | 58.214% | 1,605,698 | 984,891 |
| Cost of Sales | (447,192) | 75.575% | (254,702) | (146,637) |
| Gross Profit | 2,093,240 | 54.941% | 1,350,996 | 838,254 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (490) | -- | 332 | 147 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | |
| Profit / (Loss) before Taxation | 1,155,190 | 48.945% | 775,583 | 513,093 | |
| Taxation | (174,640) | 59.401% | (109,560) | (75,850) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 2,614 | 185.060% | 917 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 983,164 | 47.414% | 666,940 | 437,243 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (38,937) | 64.284% | (23,701) | (6,663) |
| Depreciation & Amortisation | 20,851 | 23.605% | 16,869 | 13,941 |
| Directors' Emoluments | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | |
| EPS (cts) | 99.000 | 47.761% | 67.000 | 45.000 |
| DPS (cts) | 0.000 | -- | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- |
| NBV per share ($) | 5.806 | -- | 3.528 | -- |
| Remarks: | Real time quote last updated: 14/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 983,164 |
| %Change | 47.414% |
| EPS / (LPS) | RMB 0.990 |
| NBV Per Share (¥) | RMB 5.806 |